clinical-decision-support
Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms).
Install / Use
npx skills add foryourhealth111-pixel/Vibe-Skills --skill clinical-decision-supportInstalls into whichever agent you are using.
SKILL.md
Installable skill definition
Quality Score
Category
Content & MediaSupported Platforms
Our assessment of clinical-decision-support
clinical-decision-support scores 95/100 on our quality scale, 97th of 1,153 Content & Media skills we index (top 9%).
Its SKILL.md is 26 KB long, well organised into 30 sections with 8 code examples: a thorough specification that gives an agent plenty to work with.
With 3,433 GitHub stars, it is one of the more widely adopted skills in the catalogue.
Maintenance, license and trust
- The repository was last updated about 3 months ago, so clinical-decision-support is actively maintained.
- Our last check on 2026-10-24 found the source still online.
- It is released under the Apache-2.0 license, a permissive license that allows use, modification and commercial use with attribution.
- Its trust signals score 100/100, with no cautions. These come from repository metadata, not a code audit — read the skill file before letting an agent act on it.
Safety scan
No issues foundOur scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful.
AI review by kimi-k2.7-code on 2026-10-02. Automated pattern scan on 2026-10-02. It catches known dangerous patterns, not every risk — read a skill before letting an agent act on it.
clinical-decision-support compared with similar skills
All 4 of these similar skills score higher than clinical-decision-support; compare them before choosing.
| Skill | Score | Stars | Updated | Format |
|---|---|---|---|---|
| clinical-decision-support (this skill)by foryourhealth111-pixel | 95 | 3.4k | 3mo ago | SKILL.md |
| Claude-Code-Game-Studiosby Donchitos | 100 | 39.7k | 7d ago | CLAUDE.md |
| siyuanby siyuan-note | 100 | 47.3k | today | MCP Server |
| x402by browser-use | 100 | 121.0k | 3d ago | SKILL.md |
| algorithmic-artby anthropics | 100 | 177.9k | 55d ago | SKILL.md |
Frequently asked questions
- How do I install clinical-decision-support?
- Run
npx skills add foryourhealth111-pixel/Vibe-Skills --skill clinical-decision-support. The install tabs above show the steps for each supported agent. - Which AI agents does clinical-decision-support work with?
- It is written for Zed, as a SKILL.md file. Other agents that read the same format can often use it too.
- Is clinical-decision-support safe to use?
- Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful. It is Apache-2.0-licensed and scores 100/100 on trust signals. Skills are instructions an agent will follow, so read the file before installing it and do not approve commands you do not understand.
- Is clinical-decision-support still maintained?
- The repository was last updated about 3 months ago, so clinical-decision-support is actively maintained.
Skill content
View source on GitHubname: clinical-decision-support description: "Generate professional clinical decision support (CDS) documents for pharmaceutical and clinical research settings, including patient cohort analyses (biomarker-stratified with outcomes) and treatment recommendation reports (evidence-based guidelines with decision algorithms). Supports GRADE evidence grading, statistical analysis (hazard ratios, survival curves, waterfall plots), biomarker integration, and regulatory compliance. Outputs publication-ready LaTeX/PDF format optimized for drug development, clinical research, and evidence synthesis." allowed-tools: [Read, Write, Edit, Bash]
Clinical Decision Support Documents
Description
Generate professional clinical decision support (CDS) documents for pharmaceutical companies, clinical researchers, and medical decision-makers. This skill specializes in analytical, evidence-based documents that inform treatment strategies and drug development:
- Patient Cohort Analysis - Biomarker-stratified group analyses with statistical outcome comparisons
- Treatment Recommendation Reports - Evidence-based clinical guidelines with GRADE grading and decision algorithms
All documents are generated as publication-ready LaTeX/PDF files optimized for pharmaceutical research, regulatory submissions, and clinical guideline development.
Note: For individual patient treatment plans at the bedside, use the treatment-plans skill instead. This skill focuses on group-level analyses and evidence synthesis for pharmaceutical/research settings.
Capabilities
Document Types
Patient Cohort Analysis
- Biomarker-based patient stratification (molecular subtypes, gene expression, IHC)
- Molecular subtype classification (e.g., GBM mesenchymal-immune-active vs proneural, breast cancer subtypes)
- Outcome metrics with statistical analysis (OS, PFS, ORR, DOR, DCR)
- Statistical comparisons between subgroups (hazard ratios, p-values, 95% CI)
- Survival analysis with Kaplan-Meier curves and log-rank tests
- Efficacy tables and waterfall plots
- Comparative effectiveness analyses
- Pharmaceutical cohort reporting (trial subgroups, real-world evidence)
Treatment Recommendation Reports
- Evidence-based treatment guidelines for specific disease states
- Strength of recommendation grading (GRADE system: 1A, 1B, 2A, 2B, 2C)
- Quality of evidence assessment (high, moderate, low, very low)
- Treatment algorithm flowcharts with TikZ diagrams
- Line-of-therapy sequencing based on biomarkers
- Decision pathways with clinical and molecular criteria
- Pharmaceutical strategy documents
- Clinical guideline development for medical societies
Clinical Features
- Biomarker Integration: Genomic alterations (mutations, CNV, fusions), gene expression signatures, IHC markers, PD-L1 scoring
- Statistical Analysis: Hazard ratios, p-values, confidence intervals, survival curves, Cox regression, log-rank tests
- Evidence Grading: GRADE system (1A/1B/2A/2B/2C), Oxford CEBM levels, quality of evidence assessment
- Clinical Terminology: SNOMED-CT, LOINC, proper medical nomenclature, trial nomenclature
- Regulatory Compliance: HIPAA de-identification, confidentiality headers, ICH-GCP alignment
- Professional Formatting: Compact 0.5in margins, color-coded recommendations, publication-ready, suitable for regulatory submissions
Pharmaceutical and Research Use Cases
This skill is specifically designed for pharmaceutical and clinical research applications:
Drug Development
- Phase 2/3 Trial Analyses: Biomarker-stratified efficacy and safety analyses
- Subgroup Analyses: Forest plots showing treatment effects across patient subgroups
- Companion Diagnostic Development: Linking biomarkers to drug response
- Regulatory Submissions: IND/NDA documentation with evidence summaries
Medical Affairs
- KOL Education Materials: Evidence-based treatment algorithms for thought leaders
- Medical Strategy Documents: Competitive landscape and positioning strategies
- Advisory Board Materials: Cohort analyses and treatment recommendation frameworks
- Publication Planning: Manuscript-ready analyses for peer-reviewed journals
Clinical Guidelines
- Guideline Development: Evidence synthesis with GRADE methodology for specialty societies
- Consensus Recommendations: Multi-stakeholder treatment algorithm development
- Practice Standards: Biomarker-based treatment selection criteria
- Quality Measures: Evidence-based performance metrics
Real-World Evidence
- RWE Cohort Studies: Retrospective analyses of patient cohorts from EMR data
- Comparative Effectiveness: Head-to-head treatment comparisons in real-world settings
- Outcomes Research: Long-term survival and safety in clinical practice
- Health Economics: Cost-effectiveness analyses by biomarker subgroup
When to Use
Use this skill when you need to:
- Analyze patient cohorts stratified by biomarkers, molecular subtypes, or clinical characteristics
- Generate treatment recommendation reports with evidence grading for clinical guidelines or pharmaceutical strategies
- Compare outcomes between patient subgroups with statistical analysis (survival, response rates, hazard ratios)
- Produce pharmaceutical research documents for drug development, clinical trials, or regulatory submissions
- Develop clinical practice guidelines with GRADE evidence grading and decision algorithms
- Document biomarker-guided therapy selection at the population level (not individual patients)
- Synthesize evidence from multiple trials or real-world data sources
- Create clinical decision algorithms with flowcharts for treatment sequencing
Do NOT use this skill for:
- Individual patient treatment plans (use
treatment-plansskill) - Bedside clinical care documentation (use
treatment-plansskill) - Simple patient-specific treatment protocols (use
treatment-plansskill)
Visual Enhancement with Scientific Schematics
⚠️ MANDATORY: Every clinical decision support document MUST include at least 1-2 AI-generated figures using the scientific-schematics skill.
This is not optional. Clinical decision documents require clear visual algorithms. Before finalizing any document:
- Generate at minimum ONE schematic or diagram (e.g., clinical decision algorithm, treatment pathway, or biomarker stratification tree)
- For cohort analyses: include patient flow diagram
- For treatment recommendations: include decision flowchart
How to generate figures:
- Use the scientific-schematics skill to generate AI-powered publication-quality diagrams
- Simply describe your desired diagram in natural language
- Nano Banana Pro will automatically generate, review, and refine the schematic
How to generate schematics:
python scripts/generate_schematic.py "your diagram description" -o figures/output.png
The AI will automatically:
- Create publication-quality images with proper formatting
- Review and refine through multiple iterations
- Ensure accessibility (colorblind-friendly, high contrast)
- Save outputs in the figures/ directory
When to add schematics:
- Clinical decision algorithm flowcharts
- Treatment pathway diagrams
- Biomarker stratification trees
- Patient cohort flow diagrams (CONSORT-style)
- Survival curve visualizations
- Molecular mechanism diagrams
- Any complex concept that benefits from visualization
For detailed guidance on creating schematics, refer to the scientific-schematics skill documentation.
Document Structure
CRITICAL REQUIREMENT: All clinical decision support documents MUST begin with a complete executive summary on page 1 that spans the entire first page before any table of contents or detailed sections.
Page 1 Executive Summary Structure
The first page of every CDS document should contain ONLY the executive summary with the following components:
Required Elements (all on page 1):
-
Document Title and Type
- Main title (e.g., "Biomarker-Stratified Cohort Analysis" or "Evidence-Based Treatment Recommendations")
- Subtitle with disease state and focus
-
Report Information Box (using colored tcolorbox)
- Document type and purpose
- Date of analysis/report
- Disease state and patient population
- Author/institution (if applicable)
- Analysis framework or methodology
-
Key Findings Boxes (3-5 colored boxes using tcolorbox)
- Primary Results (blue box): Main efficacy/outcome findings
- Biomarker Insights (green box): Key molecular subtype findings
- Clinical Implications (yellow/orange box): Actionable treatment implications
- Statistical Summary (gray box): Hazard ratios, p-values, key statistics
- Safety Highlights (red box, if applicable): Critical adverse events or warnings
Visual Requirements:
- Use
\thispagestyle{empty}to remove page numbers from page 1 - All content must fit on page 1 (before
\newpage) - Use colored tcolorbox environments with different colors for visual hierarchy
- Boxes should be scannable and highlight most critical information
- Use bullet points, not narrative paragraphs
- End page 1 with
\newpagebefore table of contents or detailed sections
Example First Page LaTeX Structure:
\maketitle
\thispagestyle{empty}
% Report Information Box
\begin{tcolorbox}[colback=blue!5!white, colframe=blue!75!black, title=Report Information]
\textbf{Document Type:} Patient Cohort Analysis\\
\textbf{Disease State:} HER2-Positive Metastatic Breast Cancer\\
\textbf{Analysis Date:} \today\\
\textbf{Population:} 60 patients, biomarker-stratified by HR status
\end{tcolorbox}
\vspace{0.3cm}
% Key Finding #1: Primary Results
\begin{tcolorbox}[colback=blue!5!white, colframe=blue!75!black, title=Primary Efficacy Results]
\begin{itemize}
\item Overall ORR: 72\% (95\% CI: 59-83\%)
\item Median PFS: 18.5 months (95\% CI: 14.2-22.8)
\item Median OS: 35.2 months (95\% CI: 28.1-NR)
\end{itemize}
\end{tcolorbox}
\vspace{0.3cm}
% Key Finding #2: Biomarker Insights
\begin{tcolorbox}[colback=green!5!white, colframe=green!75!black, title=Biomarker Stratification Findings]
\begin{itemize}
\item HR+/HER2+: ORR 68\%, median PFS 16.2 months
\item HR-/HER2+: ORR 78\%, median PFS 22.1 months
\item HR status significantly associated with outcomes (p=0.041)
\end{itemize}
\end{tcolorbox}
\vspace{0.3cm}
% Key Finding #3: Clinical Implications
\begin{tcolorbox}[colback=orange!5!white, colframe=orange!75!black, title=Clinical Recommendations]
\begin{itemize}
\item Strong efficacy observed regardless of HR status (Grade 1A)
\item HR-/HER2+ patients showed numerically superior outcomes
\item Treatment recommended for all HER2+ MBC patients
\end{itemize}
\end{tcolorbox}
\newpage
\tableofcontents % TOC on page 2
\newpage % Detailed content starts page 3
Patient Cohort Analysis (Detailed Sections - Page 3+)
- Cohort Characteristics: Demographics, baseline features, patient selection criteria
- Biomarker Stratification: Molecular subtypes, genomic alterations, IHC profiles
- Treatment Exposure: Therapies received, dosing, treatment duration by subgroup
- Outcome Analysis: Response rates (ORR, DCR), survival data (OS, PFS), DOR
- Statistical Methods: Kaplan-Meier survival curves, hazard ratios, log-rank tests, Cox regression
- Subgroup Comparisons: Biomarker-stratified efficacy, forest plots, statistical significance
- Safety Profile: Adverse events by subgroup, dose modifications, discontinuations
- Clinical Recommendations: Treatment implications based on biomarker profiles
- Figures: Waterfall plots, swimmer plots, survival curves, forest plots
- Tables: Demographics table, biomarker frequency, outcomes by subgroup
Treatment Recommendation Reports (Detailed Sections - Page 3+)
**Page 1 Executive Summary
Truncated for display — read the full file on GitHub.
Related Skills
Claude-Code-Game-Studios
39.7kTurn Claude Code into a full game dev studio — 49 AI agents, 72 workflow skills, and a complete coordination system mirroring real studio hierarchy.
siyuan
47.3kAn open-source, privacy-first, self-hosted knowledge workspace where humans and AI agents work together 开源、隐私优先、自托管的知识工作空间,让人与智能体在此协作
x402
121.0kSet up Browser Use Cloud payments with x402 — pay per request from a crypto wallet (USDC on Base mainnet), no signup or API key.
algorithmic-art
177.9kCreating algorithmic art using p5.js with seeded randomness and interactive parameter exploration. Use this when users request creating art using code, generative art, algorithmic art, flow fields, or particle systems.
Languages
Trust signals
From repository metadata: license, adoption, age and documentation. Not a code audit — see the Safety scan above for what the skill file itself contains.